News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,357 Results
Type
Article (14946)
Company Profile (299)
Press Release (267106)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79967)
Career Advice (163)
Deals (13345)
Drug Delivery (40)
Drug Development (50734)
Employer Resources (31)
FDA (5852)
Job Trends (5175)
News (145268)
Policy (10084)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (922)
Accelerated approval (20)
Adcomms (14)
Allergies (85)
Alliances (21799)
ALS (126)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (244)
Approvals (6047)
Artificial intelligence (268)
Autoimmune disease (119)
Automation (9)
Bankruptcy (105)
Best Places to Work (4565)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (349)
Cancer (3165)
Cardiovascular disease (243)
Career advice (148)
Career pathing (8)
CAR-T (224)
CDC (5)
Cell therapy (579)
Cervical cancer (14)
Clinical research (43750)
Collaboration (1171)
Company closure (2)
Compensation (604)
Complete response letters (42)
COVID-19 (1104)
CRISPR (88)
C-suite (569)
Cystic fibrosis (112)
Data (4367)
Denatured (15)
Depression (94)
Diabetes (256)
Diagnostics (1402)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (218)
Earnings (31744)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (51779)
Executive appointments (631)
FDA (7621)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (991)
Gene editing (185)
Generative AI (22)
Gene therapy (498)
GLP-1 (507)
Government (1152)
Grass and pollen (3)
Guidances (166)
Healthcare (6630)
HIV (18)
Huntington's disease (44)
IgA nephropathy (75)
Immunology and inflammation (194)
Immuno-oncology (43)
Indications (71)
Infectious disease (1214)
Inflammatory bowel disease (158)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (169)
Interviews (18)
IPO (7348)
IRA (13)
Job creations (868)
Job search strategy (130)
JPM (41)
Kidney cancer (9)
Labor market (24)
Layoffs (244)
Leadership (10)
Legal (1401)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (251)
Machine learning (25)
Management (7)
Manufacturing (381)
MASH (132)
Medical device (2668)
Medtech (2677)
Mergers & acquisitions (6630)
Metabolic disorders (733)
Multiple sclerosis (105)
NASH (13)
Neurodegenerative disease (234)
Neuropsychiatric disorders (70)
Neuroscience (1969)
Neurotech (1)
NextGen: Class of 2026 (2037)
Non-profit (879)
Now hiring (31)
Obesity (333)
Opinion (125)
Ovarian cancer (132)
Pain (103)
Pancreatic cancer (165)
Parkinson's disease (233)
Partnered (13)
Patents (307)
Patient recruitment (346)
Peanut (44)
People (26726)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15504)
Phase 2 (20316)
Phase 3 (12845)
Pipeline (3370)
Policy (91)
Postmarket research (853)
Preclinical (6543)
Press Release (30)
Prostate cancer (147)
Psychedelics (50)
Radiopharmaceuticals (240)
Rare diseases (666)
Real estate (1452)
Recruiting (12)
Regulatory (9936)
Reports (20)
Research institute (974)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (125)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (78)
Special edition (19)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (341)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Today (14)
Last 7 days (246)
Last 30 days (1127)
Last 365 days (17774)
2026 (1992)
2025 (18132)
2024 (20563)
2023 (22438)
2022 (26847)
2021 (27830)
2020 (23384)
2019 (16251)
2018 (11747)
2017 (13763)
2016 (11859)
2015 (14393)
2014 (10409)
2013 (7495)
2012 (7548)
2011 (7646)
2010 (7462)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18284)
Australia (3116)
California (7148)
Canada (1860)
China (784)
Colorado (249)
Connecticut (257)
Delaware (237)
Europe (39257)
Florida (916)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (399)
India (36)
Indiana (162)
Iowa (8)
Japan (228)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (751)
Massachusetts (5631)
Michigan (110)
Minnesota (250)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (34)
New Hampshire (21)
New Jersey (1664)
New Mexico (13)
New York (1778)
North Carolina (839)
North Dakota (6)
Northern California (3522)
Ohio (180)
Oklahoma (12)
Oregon (24)
Pennsylvania (1287)
Puerto Rico (9)
Rhode Island (26)
South America (215)
South Carolina (9)
Southern California (2832)
Tennessee (40)
Texas (932)
United States (23585)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
282,357 Results for "odyssey therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel
January 21, 2026
·
3 min read
IPO
Odyssey Ends Quest for Nasdaq, Pulls IPO Application After Nearly 5 Months
Odyssey filed for an IPO in January but never revealed a fundraising target.
June 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development
November 11, 2025
·
3 min read
Press Releases
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors
October 10, 2025
·
2 min read
Press Releases
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
September 11, 2025
·
5 min read
Press Releases
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
October 17, 2025
·
5 min read
Funding
Odyssey Rebounds Off Failed IPO With $213M Series D
The autoimmune and inflammatory disease–focused company canceled plans to go public earlier this year as the IPO window slammed shut.
September 10, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
January 8, 2025
·
3 min read
Press Releases
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
April 14, 2025
·
15 min read
Business
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Odyssey Therapeutics, Inc. announced today it has entered into a strategic research collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company, to jointly discover and ooptimize small molecule medicines against select therapeutic targets.
April 4, 2024
·
2 min read
1 of 28,236
Next
